HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

France considers herbal changes

This article was originally published in OTC Bulletin & The Rose Sheet

Executive Summary

The French Senate is considering ways to improve the country’s medicinal plants market by expanding the medicinal list of plants available OTC and liberalising distribution rules. The Senate received a report on a fact-finding mission to highlight the potential of medicinal plants and herbal remedies both in local areas in France and in the country’s overseas territories.

You may also be interested in...



Supermarkets Should Put Consumer Welfare Before Profits, Suggests Academic Study

A recent academic research article examining consumer healthcare shopping habits argues that, as more non-prescription medicines become available outside pharmacy, mass market retailers such as supermarkets could do more to build consumer trust.

DevaCurl Faces Multiple Class Actions As Latest Brand Linked To Hair Loss

The company maintains that its products are safe, but plaintiffs in proposed class actions allege it has knowingly put consumers at risk of hair loss and other injuries. DevaCurl’s troubles escalated quickly after a former brand ambassador went viral with a 31 January video urging consumers to stop using DevaCurl products and adopt safer alternatives.

Could ICER Outreach To US FDA Lead To Better Cost Effectiveness Analyses?

To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.

Topics

UsernamePublicRestriction

Register

RS122439

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel